Literature DB >> 27286041

Long-term Blood Pressure Measurement in Freely Moving Mice Using Telemetry.

Mohammad Afaque Alam1, Cory Parks1, Salvatore Mancarella2.   

Abstract

During the development of new vasoactive agents, arterial blood pressure monitoring is crucial for evaluating the efficacy of the new proposed drugs. Indeed, research focusing on the discovery of new potential therapeutic targets using genetically altered mice requires a reliable, long-term assessment of the systemic arterial pressure variation. Currently, the gold standard for obtaining long-term measurements of blood pressure in ambulatory mice uses implantable radio-transmitters, which require artery cannulation. This technique eliminates the need for tethering, restraining, or anesthetizing the animals which introduce stress and artifacts during data sampling. However, arterial blood pressure monitoring in mice via catheterization can be rather challenging due to the small size of the arteries. Here we present a step-by-step guide to illustrate the crucial key passages for a successful subcutaneous implantation of radio-transmitters and carotid artery cannulation in mice. We also include examples of long-term blood pressure activity taken from freely moving mice after a period of post-surgery recovery. Following this procedure will allow reliable direct blood pressure recordings from multiple animals simultaneously.

Entities:  

Mesh:

Year:  2016        PMID: 27286041      PMCID: PMC4942174          DOI: 10.3791/53991

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  11 in total

Review 1.  Cardiovascular control mechanisms in the conscious state.

Authors:  S F Vatner; E Braunwald
Journal:  N Engl J Med       Date:  1975-11-06       Impact factor: 91.245

2.  Recommendations for blood pressure measurement in humans and experimental animals. Part 2: Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research.

Authors:  Theodore W Kurtz; Karen A Griffin; Anil K Bidani; Robin L Davisson; John E Hall
Journal:  Hypertension       Date:  2004-12-20       Impact factor: 10.190

3.  Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee.

Authors:  Theodore W Kurtz; Karen A Griffin; Anil K Bidani; Robin L Davisson; John E Hall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03       Impact factor: 8.311

Review 4.  Animal models of hypertension: an overview.

Authors:  Lilach O Lerman; Alejandro R Chade; Vincenzo Sica; Claudio Napoli
Journal:  J Lab Clin Med       Date:  2005-09

5.  Arterial Pressure Monitoring in Mice.

Authors:  Xin Zhao; David Ho; Shumin Gao; Chull Hong; Dorothy E Vatner; Stephen F Vatner
Journal:  Curr Protoc Mouse Biol       Date:  2011

Review 6.  Animal models for the study of arterial hypertension.

Authors:  Waleska C Dornas; Marcelo E Silva
Journal:  J Biosci       Date:  2011-09       Impact factor: 1.826

Review 7.  Models of experimental hypertension in mice.

Authors:  C Johns; I Gavras; D E Handy; A Salomao; H Gavras
Journal:  Hypertension       Date:  1996-12       Impact factor: 10.190

8.  Persistent alterations in heart rate variability, baroreflex sensitivity, and anxiety-like behaviors during development of heart failure in the rat.

Authors:  Marcus Henze; Davin Hart; Allen Samarel; John Barakat; Laurie Eckert; Karie Scrogin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

9.  Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods.

Authors:  Steven E Whitesall; Janet B Hoff; Alan P Vollmer; Louis G D'Alecy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-02-12       Impact factor: 4.733

10.  Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia.

Authors:  Darren S Hoffmann; Christine J Weydert; Eric Lazartigues; William J Kutschke; Martha F Kienzle; Jenny E Leach; Jennifer A Sharma; Ram V Sharma; Robin L Davisson
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

View more
  5 in total

1.  Treatment with dimethyl fumarate reduces the formation and rupture of intracranial aneurysms: Role of Nrf2 activation.

Authors:  Crissey L Pascale; Alejandra N Martinez; Christopher Carr; David M Sawyer; Marcelo Ribeiro-Alves; Mimi Chen; Devon B O'Donnell; Jessie J Guidry; Peter S Amenta; Aaron S Dumont
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-20       Impact factor: 6.200

2.  Elevated plasma catecholamines functionally compensate for the reduced myogenic tone in smooth muscle STIM1 knockout mice but with deleterious cardiac effects.

Authors:  Prahalathan Pichavaram; Wen Yin; Kirk W Evanson; Jonathan H Jaggar; Salvatore Mancarella
Journal:  Cardiovasc Res       Date:  2018-04-01       Impact factor: 10.787

3.  TREK-1 protects the heart against ischemia-reperfusion-induced injury and from adverse remodeling after myocardial infarction.

Authors:  Samuel Kamatham; Christopher M Waters; Andreas Schwingshackl; Salvatore Mancarella
Journal:  Pflugers Arch       Date:  2019-09-12       Impact factor: 3.657

4.  A cardiac-null mutation of Prdm16 causes hypotension in mice with cardiac hypertrophy via increased nitric oxide synthase 1.

Authors:  Ji-One Kang; Tae Woong Ha; Hae-Un Jung; Ji Eun Lim; Bermseok Oh
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

5.  The effect of continuous intravenous norepinephrine infusion on systemic hemodynamics in a telemetrically-monitored mouse model of sepsis.

Authors:  Tetsushi Yamashita; Jonathan M Street; Brianna C Halasa; Yoshitaka Naito; Takayuki Tsuji; Naoko Tsuji; Naoki Hayase; Peter S T Yuen; Robert A Star
Journal:  PLoS One       Date:  2022-08-11       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.